These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20380153)

  • 1. Restoration of expression of MHC class I molecule in Walker 256 tumor in growth dynamics in Brattleboro rats.
    Mafanasyeva MA; Zakharova LA; Khegai II; Sharova NP; Popova NA; Ivanova LN; Melnikova VI
    Dokl Biochem Biophys; 2010; 430():11-3. PubMed ID: 20380153
    [No Abstract]   [Full Text] [Related]  

  • 2. Pattern of MHC class I and immune proteasome expression in Walker 256 tumor during growth and regression in Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis.
    Zakharova LA; Khegai II; Sharova NP; Melnikova VI; Karpova YD; Astakhova TM; Popova NA; Ivanova LN
    Cell Immunol; 2011; 271(2):385-91. PubMed ID: 21889127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of the RT1A molecule of the class I major histocompatibility complex in a Walker 256 tumor after transplantation into Brattleboro rats with a genetic defect of arginine-vasopressin synthesis].
    Mel'nikova VI; Khegaĭ II; Afanas'eva MA; Ivanova LN; Zakharova LA
    Izv Akad Nauk Ser Biol; 2013; (1):99-102. PubMed ID: 23662467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concordance between vasopressin gene expression and growth of Walker 256 carcinosarcoma in rats].
    Khegaĭ II
    Genetika; 2013 Apr; 49(4):538-40. PubMed ID: 23866631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Walker 256 tumor growth in rats with hereditary defect of vasopressin synthesis.
    Khegai II; Popova NA; Zakharova LA; Ivanova LN
    Bull Exp Biol Med; 2006 Sep; 142(3):344-6. PubMed ID: 17426845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of Walker 256 carcinosarcoma in vasopressin-deficient Brattleboro rats is accompanied by a changed laminin pattern.
    Khegay II; Ivanova LN
    Biochem Genet; 2015 Apr; 53(1-3):1-7. PubMed ID: 25854851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Walker 256 carcinosarcoma growth in vasopressin-deficient Brattleboro rats.
    Khegay II; Popova NA; Ivanova LN
    Tumour Biol; 2010 Dec; 31(6):569-73. PubMed ID: 20559788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Walker 256 tumor MHC class I expression during the shift from A variant to the immunogenic AR variant.
    Schanoski AS; Cavalcanti TC; Campos CB; Viera-Matos AN; Rettori O; Guimarães F
    Cancer Lett; 2004 Jul; 211(1):119-27. PubMed ID: 15194224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of tumor growth in Brattleboro and WAG rats injected with Walker 256 carcinosarcoma cells in different doses.
    Khegay II; Popova NA; Ganilova LS; Shnyder EP; Ivanova LN
    Bull Exp Biol Med; 2008 Jan; 145(1):81-3. PubMed ID: 19024010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of proteasome expression in Walker 256 tumor cells after their transplantation into the Brattleboro rats with genetic defect of vasopressin synthesis.
    Sharova NP; Melnikova VI; Khegai II; Karpovaa YD; Dmitrieva SB; Astakhova TM; Afanas'eva MA; Popova NA; Ivanova LN; Zakharova LA
    Dokl Biochem Biophys; 2008; 419():93-7. PubMed ID: 18505166
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of vasopressin gene expression on the growth of Walker 256 carcinosarcoma in rats].
    Khegaĭ II; Popova NA; Ivanova LN
    Genetika; 2006 Jul; 42(7):993-5. PubMed ID: 16915932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal dependency of Walker 256 carcinosarcoma growing in rats].
    Khegaĭ II
    Ross Fiziol Zh Im I M Sechenova; 2008 Nov; 94(11):1335-9. PubMed ID: 19140311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats.
    Chekhun VF; Storchai DM; Todor IN; Borikun TV; Lukianova NY
    Exp Oncol; 2018 Oct; 40(3):200-204. PubMed ID: 30284996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On defined tumor-tolerant and tumor-resistant strains of CFN rats. (Genetic and immunobiological problems in the transplantation of Walker-256 carcinosarcoma in various homologous hosts)].
    Lehmann FE; Meyer V
    Arch Julius Klaus Stift Vererbungsforsch Sozialanthropol Rassenhyg; 1963; 38(3-4):242-52. PubMed ID: 5899906
    [No Abstract]   [Full Text] [Related]  

  • 15. MHC class I antigens and immune surveillance in transformed cells.
    Aptsiauri N; Cabrera T; Garcia-Lora A; Lopez-Nevot MA; Ruiz-Cabello F; Garrido F
    Int Rev Cytol; 2007; 256():139-89. PubMed ID: 17241907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic characterisation of the optimised rat model of Walker 256 breast cancer cell-induced bone pain.
    Shenoy PA; Kuo A; Leparc G; Hildebrandt T; Rust W; Nicholson JR; Corradini L; Vetter I; Smith MT
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1201-1215. PubMed ID: 31429474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features of the immune proteasome expression in ascite Zajdela hepatoma after implantation into Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis].
    Mel'nikova VI; Khegaĭ II; Popova NA; Lifantseva NV; Ivanova LN; Zaharova LA
    Bioorg Khim; 2014; 40(6):712-9. PubMed ID: 25895368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-expression of major histocompatibility complex (MHC) class I molecules on malignant tumor cells and its effect on host-tumor interaction.
    Hui KM
    Bioessays; 1989 Jul; 11(1):22-6. PubMed ID: 2673229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fish oil administration mediates apoptosis of Walker 256 tumor cells by modulation of p53, Bcl-2, caspase-7 and caspase-3 protein expression.
    Borghetti G; Yamaguchi AA; Aikawa J; Yamazaki RK; de Brito GA; Fernandes LC
    Lipids Health Dis; 2015 Aug; 14():94. PubMed ID: 26303118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.